Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)

NCT00158522

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: National Hepatology and Tropical Medicine Research Institute Cairo, Egypt

View Trial Details

Completed

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

NCT00610597

Conditions: Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Liver Disease, +21 more
Locations: Hopital Erasme - Dpt of Gastroenterology Brussels, Belgium

View Trial Details

Completed

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

NCT00118924

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Vanderbilt University School of Medicine Nashville, Tennessee, United States

View Trial Details

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

NCT00094705

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +9 more
Locations: Johns Hopkins School of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

NCT00292084

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Halifax, Nova Scotia, Canada

View Trial Details

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

NCT00089908

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +9 more
Locations: Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

NCT00040027

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: University of Alabama - Knollwood Physician's Group Bldg. Mobile, Alabama, United States

Mayo Clinic Scottsdale, Arizona, United States

Gastroenterology Associates of East Bay Medical Group Berkeley, California, United States

Scripps Clinic La Jolla, California, United States

View all 48 locations

View Trial Details

Completed

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

NCT00039962

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: University of Alabama - Knollwood Physician's Group Mobile, Alabama, United States

Mayo Clinic Scottsdale, Arizona, United States

Advanced Clinical Research Institute Anaheim, California, United States

Gastroenterology Associates of East Bay Medical Group Berkeley, California, United States

View all 56 locations

View Trial Details

Completed

Short Course of Interferon Treatment in Patients With HCV Infection

NCT00502970

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +13 more
Locations: The Aga Khan University, Stadium Road Karachi, Sindh, Pakistan

View Trial Details

Completed

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

NCT00372983

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details